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Abstract  
Background 
Women with diabetes are at increased risk of adverse maternal and fetal outcomes. 
Preconception care can improve pregnancy outcomes and is paramount to minimise 
complications, but, current provision is sub-optimal. Mobile technology, particularly 
smartphones and apps have the potential to improve preconception care provision but 
research is lacking in this area. The need to use modern technologies to improve 
preconception care knowledge and awareness led to the development of a Preconception 
and Diabetes Information app in stage A of this study. 
Objective 
The aim of this paper, stage B of the study, is to explore the feasibility and acceptability 
of the Preconception and Diabetes Information app to improve preconception care 
knowledge and attitudes in women with diabetes, and explore the potential for wider 
implementation.   
Methods 
A mixed methods study design adopting a quasi-experimental approach will assess 
women’s knowledge and attitudes related to preconception care, and level of patient 
activation (knowledge and confidence for self-management of health) before and after 
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the 3 month intervention period. A log of activity will be used to determine engagement 
with the app and semi-structured interviews will explore women’s experiences.  
Conclusions 
This is the first study to explore the acceptability and feasibility of a Preconception and 
Diabetes Information app for women with diabetes. The app has potential to change the 
way preconception care is delivered, improve pregnancy outcomes and be widely 
implemented in both developed and developing countries. This is important given the 
considerable shortfalls in current preconception care services in the United Kingdom 
and around the world.  
Keywords 
Preconception care; education; diabetes mellitus; women; smartphones; mobile 
applications; mobile health; technology.  
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Introduction 
Diabetes mellitus (DM) has been deemed a global emergency.1,2 Worldwide, 415 
million adults have DM and by 2040, this is predicted to rise to 642 million adults.2 
There are two main types of DM that affect women before pregnancy: type 1 (the 
pancreas does not produce any insulin) and type 2 (the amount of insulin produced by 
the pancreas is insufficient or the body develops a resistance to insulin produced).1,2 
DM is the most common pre-existing medical condition that can complicate pregnancy 
creating considerable risks for both mother and child.3-5 Poorly controlled DM together 
with unplanned pregnancy increases the risk of maternal and fetal complications. In 
addition to the increased risk of fetal and maternal death, common complications 
include miscarriage, birth defects, preterm labour and birth injury, 3-6 the risks of which 
can be minimised through preconception care (PCC). This is targeted medical care and 
advice about pregnancy planning which can improve pregnancy outcomes by increasing 
knowledge and supporting women to adopt healthy behaviours e.g. blood glucose 
monitoring and folic acid use before pregnancy.3,5,7-12 Clinical guidelines recommend 
that PCC is provided to all women with DM once they reach adolescence.3,6,13,14 
However, evidence suggests that PCC is hindered by poor implementation of clinical 
guidelines,11,15,16 provider and patient-level barriers,10,12,16 sub-optimal uptake10,17 and 
inadequate knowledge of PCC.8,12  These have negative implications for women with 
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DM around the world, especially those in developing countries who are at greatest risk 
of adverse pregnancy outcomes.18      
 
There is therefore a need to adopt more innovative approaches to delivering PCC. 
Evidence suggests that while PCC delivered by multimedia i.e. CD-ROMs and DVDs 19-
22 is feasible and effective in raising awareness of PCC in women with DM, 12 these 
multimedia technologies are now outdated. Consequently they offer limited scope to the 
many women without access to computers or DVD players who increasingly rely on 
apps delivered by smartphones to access health information.23 The smartphone is the 
most popular mobile device, with over a billion users worldwide.23 It is technologically 
advanced, easily accessible, mobile and offers the opportunity to penetrate a larger 
population.23,24 In most developed countries, smartphones are ingrained into daily life 
while in developing economies, usage is proliferating rapidly and is expected to 
approach levels seen in developed countries.24 Most smartphone functionalities are 
aided by apps (software designed to run on smartphones), and in a recent qualitative 
study, women with DM suggested development of a PCC app to help convey PCC 
education, increase knowledge of diabetes and pregnancy and improve PCC uptake.8  
 
The increasing availability of health information in easily accessible digital format is 
rapidly changing the health education and information paradigm.25 There is some 
5 
 
evidence to suggest that Apps can help improve women’s knowledge of family planning 
and contraception26 and to reduce body mass index (BMI).27 They have also contributed 
to healthy behavioural changes in other areas— medication management, diet control, 
physical activity, lifestyle improvement, smoking cessation and diabetes management.28 
The acceptance, coverage and effectiveness of apps in improving knowledge and 
enhancing behaviour change, coupled with the need for increased PCC awareness and 
uptake in women with DM, led to the development of a Preconception and Diabetes 
Information (PADI) app in Stage A of this study. The PADI app is designed to provide 
flexible and easy access to information about PCC, blood glucose monitoring and 
support women with DM to optimise their health from preconception to early 
pregnancy. This paper presents stage B of the study, the primary aim of which is to test 
the feasibility and acceptability of the PADI app and explore its potential for wider 
implementation.   
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Methods 
Study design 
A mixed methods29-31 study design incorporating several data collection methods will be 
used to explore the feasibility of the PADI app for women with type 1 DM (T1DM) and 
type 2 DM (T2DM). A longitudinal quasi-experimental approach with two data 
collection points, at the beginning and end of 3 months of app usage (Figure 1) will be 
used to assess women’s knowledge and attitudes to PCC. The quasi experiment will not 
involve an external control group, outcomes will be measured before participants 
receive the intervention and again after the intervention, and any changes in 
measurement compared within the individuals over a period of time to determine the 
impact of the intervention.32,33  A log of activity will be used to determine engagement 
with the app, a simple visual scale will measure satisfaction and semi-structured 
interviews will explore women’s experiences of app usage.  
 
Conceptual Framework 
The Normalisation Process Theory (NPT) 34 provides the theoretical basis for this study. 
The NPT provides a framework that is useful for assessing and enhancing the 
implementation potential of technological interventions. It addresses the factors for 
successful implementation and integration of health interventions into routine practice, a 
process known as normalisation. The four components of the NPT (Table 1); were 
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considered before and during the development of the app, and incorporated into the 
design of this feasibility study. 
Table 1. Components of the Normalisation Process Theory 
Component Related Questions 
1. Coherence or sense-making (the 
meaning the intervention makes to 
participants) 
Is the intervention easy to understand and 
what benefits will it bring and to whom?  
2. Cognitive participation or engagement 
(commitment made by participants) 
Will the target user groups see it as a good 
idea and will they be prepared to invest 
time, energy and work into it? 
3. Collective action (effort invested in the 
intervention by participants) 
How will the intervention affect the work 
of user groups, will it promote or impede 
their work, and what effect will it have on 
health services e.g. consultation time. 
4. Reflexive monitoring (appraisal of the 
intervention by participants)  
How will users perceive use of the 
intervention, can users contribute feedback 
about the intervention, and is there room 
for the intervention to be improved 
following user experience? 
Ethical Review  
Favourable ethical opinion was obtained from United Kingdom National Research 
Ethics Service (UK NRES) Committee East Midlands-Derby; REC reference 
15/EM/0358; IRAS project ID: 178530.  
Recruitment  
Participants will be recruited from two National Health Service (NHS) hospitals in the 
South of England and via Social Media (i.e. twitter).  Eligible participants who attend 
the outpatient clinics at the hospitals will be approached by a member of the healthcare 
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team when they come for their clinic appointments and asked if they are willing to 
speak to a researcher (CHN) about testing the PADI app. A twitter advert will be sent 
out inviting eligible participants to contact the study researcher if they are interested in 
taking part in the study. If participants indicate interest, they will be asked to provide 
the researcher (CHN) with their contact details. Potentially eligible participants will 
receive an introduction to the study face-to-face, by mail or telephone. It will be made 
clear in all information provided to participants that they do not have to participate in 
the study and that they can withdraw from the study at any time without prejudicing 
their care. All potentially eligible participants will be screened for eligibility against the 
following inclusion criteria: 
 Woman of reproductive age (18-45 years) with T1DM or T2DM. 
 Diagnosis of diabetes by a healthcare professional for more than 6 months. 
 Currently are not pregnant, but are planning a future pregnancy (in the next 5 years) 
or want children sometime in the future 
 Own a smartphone (iOS or Android).  
Those who meet the inclusion criteria will be provided with a written participant 
information sheet (PIS) informing them about the study. They will be given the 
opportunity to ask questions and written consent to participate in the study will be 
obtained prior to study commencement. Only eligible participants who provide written 
informed consent will be enrolled into the study.  
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Sample 
A purposive sample of patients with T1DM and T2DM will be recruited into the study, 
from two NHS hospitals in the South of England and via Social Media. For feasibility 
studies, a sample size of 12 is considered sufficient.35 Participants for the intervention 
phase will comprise (n=15-20) women with DM, with attrition (or drop-outs) estimated 
at 20%.36 Figure 1 provides a flow chart of participants through the study.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Screening for eligibility  
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 Declined participation 
 
 
 
Consent  
Yes No 
Enrol into study, receive app 
demonstration and complete baseline 
questionnaire (Q1) 
 
Excluded 
 Eligible but declined 
participation 
Included (n=15-20) 
App usage for 3 months  
Administration of Q2 and 
Patient evaluative interviews 
Analysis 
 Usage log/frequency 
 Questionnaire (Q1 and Q2) 
 Interviews 
 
S
cr
ee
n
in
g
 
B
as
el
in
e 
In
te
rv
en
ti
o
n
 
C
o
m
p
le
ti
o
n
 
11 
 
Figure 1  Study flow diagram 
 
Intervention 
All eligible participants enrolled into the study will receive the intervention. It is 
anticipated that participants will utilise the PADI app for at least 5 minutes a day, 35 
minutes a week and 7 hours over 3 months to (1) access preconception information and 
(2) record their blood glucose level.  
Preconception and Diabetes Information (PADI) app development 
A co-design approach was used to develop the PADI app (Figure 2) to help ensure that 
it met the needs of women and that its content was appropriate and acceptable.37-40 The 
PADI development team included women with DM (app development working group), 
healthcare professionals (expert advisory group) and a digital agency (Netsells Ltd).  
 
Content development 
The PADI app content was based on a series of focus groups and interviews with the 
expert advisory group and app development working group; the majority of which were 
supportive of using technology to support PCC. The app content was also informed by 
previous research in this area (Holmes et al. 21) and the findings from a recent literature 
review.10 
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Expert advisory group 
The expert advisory group comprised of doctors (general practitioner, obstetrician, 
endocrinologist) and nurses (research and specialist) who suggested including the 
following information: importance of planning pregnancy and using contraception until 
stable HbA1c is achieved, pregnancy-related risks for the woman and baby, and general 
health advice for the preconception period.  
App development working group 
The app development working group included women of childbearing age with type 1 
and 2 DM, age range 22-43 years, with and without prior pregnancies. They expressed 
desire for easily accessible and comprehensive PCC information that was provided 
using a positive and supportive language.  
Both groups were of the opinion that the information should extend beyond 
preconception to include diabetes and pregnancy, particularly what to expect during 
pregnancy and delivery. They suggested including a blood glucose diary, reminder and 
graph to help women track and visualise their blood glucose levels in the run up to 
pregnancy, and wanted a PCC app that was attractive, simple and user-friendly.  
PADI app design and prototype development 
The app design was discussed with the app developer (Netsells) who then created 
wireframes, a visual guide representing the skeletal framework of the app. The 
wireframes were used to detail the app layout, prioritise components and determine how 
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the app screens will link together. They took into account the functionality of the 
screen, content, layout, app behaviour and sequencing of the app’s function. The output 
of the wireframe work was then used to create an initial prototype, a design model of 
the final user interface (UI), which gave the first detailed impression of how the UI or 
app screens would look and work. The app prototype was designed to provide a series 
of informational pages and a place to submit and view blood glucose readings by day, 
week and month. This initial design output however highlighted potential usability 
issues regarding the layout, colours and navigation. The prototype was then revised 
several times to ensure that the final user interface was both simple, user friendly and 
attractive.  
 
PADI was developed in both Swift (programming language for iOS) and Java (android 
development language) in order to run on both Apple’s iOS and Google’s Android 
platforms. An application programming interface (API) was also developed to allow the 
storage and retrieval of individual records of information. The API routine connects 
PADI to Netsells’ remote server and along with the creation of user accounts, allows 
authentication with the data in the database. The API was developed using one of the 
most popular programming languages for web application backend development, 
Hypertext Preprocessor (PHP) framework Laravel.41 The resulting prototype was tested 
by Netsells in-house to ensure optimal functionality before being released for further 
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testing. The final prototype was presented to a selection of participants (healthcare 
professionals, women with DM, researchers and members of the public) to test the full 
app functionality for a period of 14 days and provide feedback. The piloting comprised 
two cycles of feedback and resulted in minor textual changes, modification of the blood 
glucose diary, and rectification of an error with the graphical display of blood glucose 
readings. This process was deemed complete when the modifications made were tested 
by participants and their needs satisfied.  
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Figure 2: Diagrammatic representation of PADI app development process 
 
Features of the final PADI app  
Screenshots of the final app (Figure 3) shows the following features: Planning for 
pregnancy and blood glucose diary with graphical display and reminder. The core 
aspects of these features and their purpose within the app are shown in Table 2.  
 
Table 2 PADI app feature description 
Features  
 
Aspects of the feature Purpose 
Planning for 
pregnancy 
drafted in line 
with National 
Institute for 
Clinical 
Excellence 
(NICE) 
preconception 
care guidelines3 
This feature comprises of 13 sections with 
information on the various aspects of preparing for 
pregnancy and what to expect during pregnancy 
and delivery. In addition to textual information, it 
contains videos and uniform resource locators 
(URLs) that users can click on to view more 
information on a specific topic. These URLs take 
users out of the app and to reliable external 
websites such as Diabetes UK, 42 NICE 
guidelines,3 Family Planning Association (FPA)43 
and womenwithdiabetes.net.21, 44 PADI app icon 
will remain at the top of the page and users can 
use this to navigate back to their current session in 
the app.  
 
Promote knowledge 
of PCC and 
pregnancy planning.  
Blood glucose 
diary 
(represented 
both in text 
format and 
through data 
visualisation) 
Blood glucose (BG) readings throughout the day 
are recorded. Frequency depends on number of 
times BG reading is taken and as advised by a 
healthcare professional. Users are able to select 
the current time of day from a drop-down menu 
e.g. before breakfast. The time of reading is 
automatically set and users have the option of 
being reminded to take their next reading before 
To record and keep 
track of BG reading. 
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saving the BG reading. The list of entries is then 
displayed starting with the oldest to the most 
recent. 
 
Reminders These are set when a new reading is added. A 
notification is sent to the user’s phone at their set 
reminder time. Users have the option to deactivate 
set reminders by toggling the switch. 
 
Reminder to take 
BG reading and help 
keep a regular BG 
reading schedule. 
Progress The inputted BG information is further broken 
down into daily averages and represented in a 
graph. BG readings outside recommended PCC 
target range (4-9 mmol/l) triggers a pop up feature 
and highlights the reading. Clicking on the pop up 
redirects users to the BG management page within 
the app. Users can choose how they want their 
progress displayed, e.g. today, past 7 days or 30 
days.  
To display the user’s 
progress and help 
monitor trends. 
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Figure 3: Screenshots of the final PADI app  
19 
 
Outcome measures  
As a feasibility study evaluating the process and/ acceptability of the intervention to 
users there is no primary outcome measure.45,46 The study will explore women's 
satisfaction and experiences of using the PADI app, and provide preliminary outcome 
estimates i.e. knowledge of preconception care, patient activation measure (PAM) and 
attitudinal change to PCC. Evaluative semi-structured interviews and log of activity 
after the 3-months of app use will seek to explore perceived acceptability, utility and 
usability of the app.  
Data Collection 
Background information: information will be collected on participants’ demographics 
and baseline characteristics. A section containing questions aimed at capturing these 
background data will be included in the patient questionnaires (Q1) administered on 
enrolment.  
Patient questionnaires: these will be administered at two time points, on enrolment (at 
baseline) and following 3 months of PADI app usage, and will be informed by 
previously validated tools involving Patient Activation Measures (PAM), 47,48 
reproductive health and diabetes instrument (RHAB) 49 and knowledge of PCC.21 These 
evaluative questionnaires will be used to compare PAM, knowledge and attitudes to 
PCC before (pre) and after (post) intervention. At the end of the study, patients will be 
required to repeat the initial questionnaire (but without background information) (Q2). 
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Software log of activity: will provide information on the frequency of use of the App for 
accessing informational pages and for self-monitoring activities i.e. logging of blood 
glucose. This will be used to demonstrate uptake/utilization of PADI’s features. PADI 
has inbuilt analytics that support collection of this data, which will be stored on a secure 
server accessible only to the App development company who will then ensure secure 
transfer to the researcher (CHN) to allow data analysis. 
Patient interviews: semi-structured face to face or telephone interviews will be 
undertaken at the end of the study, 40-60 minutes with the first 6-8 participants30 from 
the intervention who consent to being interviewed. Interviews will explore their 
experience of using PADI and from this, common themes will be identified regarding 
acceptability, impediments to regular usage and suggestions for improvement.40 The 
interview schedule will be informed by previously published protocols for exploring 
participant experience of using an App.50  
Data management and analysis 
Microsoft Excel© will be used for the organisation, collation and recording of the 
quantitative data from each participant. Processing of the questionnaire will be 
consistent and a clear record of the returned questionnaires will be kept. Each 
participant will be assigned a number and the same number will be used throughout the 
study to allow the data on demographic information, knowledge and attitudes to PCC 
and PAM to be correlated. A coding manual will be developed for each questionnaire 
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and used during the data entry process. The responses will be assigned numerical codes 
and recorded in the codebook. The data will then be entered into Excel spreadsheets and 
later imported into SPSS® version 22 for analysis. Descriptive statistics will provide 
preliminary estimates of key parameters, as recommended for feasibility studies.45,46  
 
Content data from the open questions will be coded by assigning data to categories and 
then labelling the categories. Qualitative data (interviews) will be analysed using 
inductive thematic analysis.51 Interviews will be recorded, transcribed verbatim, and 
anonymised. QSR Nvivo 1052 will be used as a data handling management system for 
the data collected from the interviews. Nvivo will be used mainly for the advantages it 
offers in allowing large volumes of data to be handled with speed, preparing conceptual 
maps of coded data, facilitating exploration of relationships between codes, and aiding 
interpretation and theorising. 33,51,52  
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Discussion 
This paper presents a mixed methods protocol that is designed to examine the 
acceptability and feasibility of the Preconception and Diabetes Information (PADI) app 
intervention. PADI incorporates both PCC information and self-monitoring of blood 
glucose (SMBG) functions. PCC education has been widely recommended as an 
effective strategy to promote PCC knowledge and encourage behaviour 
change.3,6,13,14,18,53 SMBG is a vital part of managing glycaemic control and optimised 
glycaemic control is a core component of PCC. Mobile phones have been shown to 
improve glycaemic control in patients with DM54-56 and the effectiveness of 
technological innovations in improving PCC knowledge and attitude have been 
demonstrated.19-22 PADI is designed to improve awareness of PCC and to support 
women with T1DM and T2DM adopt behaviours that support a healthy pregnancy and 
baby such as regular blood glucose monitoring, folic acid intake, lifestyle modification 
and use of contraception until optimum blood glucose levels are achieved. 
 
Health interventions utilising mobile technologies offer many advantages including the 
potential for wide scale implementation and dissemination.40 They are also able to 
penetrate disadvantaged or resource-poor settings including developing countries, 
thereby expanding the reach of health information to underserved communities in line 
with the United Nations sustainable development goals.57,58 Successful implementation 
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of a technological innovation however requires careful consideration of several factors. 
For example, an intervention that is perceived as providing limited benefits, difficult to 
understand or fit into normal everyday practice would not appeal to healthcare 
professionals or policy makers.34,40 In order to maximise benefit, it is important for 
technological interventions to be accepted by the target population and normalised into 
practice.34,40 While a healthcare professional may recommend a smartphone app, it is 
ultimately up to those concerned to determine if the app is beneficial and worth an 
investment of their time.59 Therefore, to increase PADI’s potential for wide-scale 
adoption and implementation, women with DM and their healthcare providers were 
involved in its design and development, and the NPT framework34 was used to optimise 
the app development and inform the study design.  
 
This is the first study to test the feasibility of a Preconception app specifically 
developed for women with DM. Findings of the study will enhance understanding of the 
role of apps in PCC of women with DM and provide insight into their use for promoting 
PCC awareness and behaviour change. It is anticipated that PADI will provide an 
innovative way of providing more women with DM with information on PCC. This is 
important given the barriers associated with traditional PCC practice8,12,15,17 and the 
limited technology that is available to support PCC services.10 Given these limitations, 
the PADI app has been designed for both Apple iOS and Google Android, the two 
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leading mobile operating systems.60 If this study is successful, it will provide the 
platform for a larger study to evaluate a potentially feasible and easy-to-implement 
intervention that can be integrated into healthcare and provide evidence of its effect on 
patient outcomes. However for this study, participants will be required to download the 
app onto their own phones and need to own a smartphone to be eligible to participate. 
Repeated examination of preliminary outcomes within three months may introduce 
some information bias into the study. Also, being a feasibility study, the sample size for 
the quantitative phase is quite small, limiting the generalizability of the study findings 
to other contexts and populations. 
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Conclusion 
The prevalence of DM in women of reproductive age is growing and improved PCC 
awareness is urgently required to reduce poor maternal and perinatal outcomes 
experienced by women with DM, particularly in low and middle income countries. 
Mobile technology, mainly smartphones and apps, have the potential to improve PCC 
and obstetric outcomes for women with DM around the world, but, research is lacking 
in this area. This is the first study to explore the acceptability and feasibility of a 
Preconception app for women with DM and the findings will inform the development of 
a larger study. PADI could be easily integrated into healthcare, scaled up and adapted 
into a sustainable PCC intervention programme which could be widely implemented, 
particularly in developing countries where women have the highest risk of adverse 
pregnancy outcomes. This is important given the considerable shortfalls in current PCC 
provision around the world and in the United Kingdom.  
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